HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.

Ivonne Haffner; Katrin Schierle; Elba Raimúndez; Birgitta Geier; Dieter Maier; Jan Hasenauer; Birgit Luber; Axel Walch; Katharina Kolbe; Jorge Riera Knorrenschild; Albrecht Kretzschmar; Beate Rau; Ludwig Fischer von Weikersthal; Miriam Ahlborn; Gabriele Siegler; Stefan Fuxius; Thomas Decker; Christian Wittekind; Florian Lordick

doi:10.1200/JCO.20.02761

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.

Ivonne Haffner
, Katrin Schierle
, Elba Raimúndez
, Birgitta Geier
, Dieter Maier
, Jan Hasenauer
, Birgit Luber
, Axel Walch
, Katharina Kolbe
, Jorge Riera Knorrenschild
, Albrecht Kretzschmar
, Beate Rau
, Ludwig Fischer von Weikersthal
, Miriam Ahlborn
, Gabriele Siegler (Co-author)
, Stefan Fuxius
, Thomas Decker
, Christian Wittekind
, Florian Lordick

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

88 Citations (Web of Science)

Original language	English
Pages (from-to)	1468-1478
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	39
Issue number	13
DOIs	https://doi.org/10.1200/JCO.20.02761
Publication status	Published - 2021

Keywords

GASTROESOPHAGEAL CANCER
GENE AMPLIFICATION
TRASTUZUMAB
ADENOCARCINOMA
THERAPY
HETEROGENEITY
SENSITIVITY
RESISTANCE
PROGNOSIS

Access to Document

10.1200/JCO.20.02761

Cite this

Haffner, I., Schierle, K., Raimúndez, E., Geier, B., Maier, D., Hasenauer, J., Luber, B., Walch, A., Kolbe, K., Riera Knorrenschild, J., Kretzschmar, A., Rau, B., Fischer von Weikersthal, L., Ahlborn, M., Siegler, G., Fuxius, S., Decker, T., Wittekind, C., & Lordick, F. (2021). HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. JOURNAL OF CLINICAL ONCOLOGY , 39(13), 1468-1478. https://doi.org/10.1200/JCO.20.02761

Haffner, Ivonne ; Schierle, Katrin ; Raimúndez, Elba et al. / HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. In: JOURNAL OF CLINICAL ONCOLOGY 2021 ; Vol. 39, No. 13. pp. 1468-1478.

@article{330d77172e6c4d819ad048c5a4dc172f,

title = "HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.",

keywords = "GASTROESOPHAGEAL CANCER, GENE AMPLIFICATION, TRASTUZUMAB, ADENOCARCINOMA, THERAPY, HETEROGENEITY, SENSITIVITY, RESISTANCE, PROGNOSIS",

author = "Ivonne Haffner and Katrin Schierle and Elba Raim{\'u}ndez and Birgitta Geier and Dieter Maier and Jan Hasenauer and Birgit Luber and Axel Walch and Katharina Kolbe and \{Riera Knorrenschild\}, Jorge and Albrecht Kretzschmar and Beate Rau and \{Fischer von Weikersthal\}, Ludwig and Miriam Ahlborn and Gabriele Siegler and Stefan Fuxius and Thomas Decker and Christian Wittekind and Florian Lordick",

note = "Siegler: Paracelsus Med Privatuniv Nurnberg, Klinikum Nurnberg, Dept Internal Med Hematol *** Med Oncol, Nurnberg, Germany; ",

year = "2021",

doi = "10.1200/JCO.20.02761",

language = "English",

volume = "39",

pages = "1468--1478",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins ",

number = "13",

}

Haffner, I, Schierle, K, Raimúndez, E, Geier, B, Maier, D, Hasenauer, J, Luber, B, Walch, A, Kolbe, K, Riera Knorrenschild, J, Kretzschmar, A, Rau, B, Fischer von Weikersthal, L, Ahlborn, M, Siegler, G, Fuxius, S, Decker, T, Wittekind, C & Lordick, F 2021, 'HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.', JOURNAL OF CLINICAL ONCOLOGY , vol. 39, no. 13, pp. 1468-1478. https://doi.org/10.1200/JCO.20.02761

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. / Haffner, Ivonne; Schierle, Katrin; Raimúndez, Elba et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 39, No. 13, 2021, p. 1468-1478.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.

AU - Haffner, Ivonne

AU - Schierle, Katrin

AU - Raimúndez, Elba

AU - Geier, Birgitta

AU - Maier, Dieter

AU - Hasenauer, Jan

AU - Luber, Birgit

AU - Walch, Axel

AU - Kolbe, Katharina

AU - Riera Knorrenschild, Jorge

AU - Kretzschmar, Albrecht

AU - Rau, Beate

AU - Fischer von Weikersthal, Ludwig

AU - Ahlborn, Miriam

AU - Siegler, Gabriele

AU - Fuxius, Stefan

AU - Decker, Thomas

AU - Wittekind, Christian

AU - Lordick, Florian

N1 - Siegler: Paracelsus Med Privatuniv Nurnberg, Klinikum Nurnberg, Dept Internal Med Hematol *** Med Oncol, Nurnberg, Germany;

PY - 2021

Y1 - 2021

KW - GASTROESOPHAGEAL CANCER

KW - GENE AMPLIFICATION

KW - TRASTUZUMAB

KW - ADENOCARCINOMA

KW - THERAPY

KW - HETEROGENEITY

KW - SENSITIVITY

KW - RESISTANCE

KW - PROGNOSIS

U2 - 10.1200/JCO.20.02761

DO - 10.1200/JCO.20.02761

M3 - Original Article

C2 - 33764808

SN - 0732-183X

VL - 39

SP - 1468

EP - 1478

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 13

ER -

Haffner I, Schierle K, Raimúndez E, Geier B, Maier D, Hasenauer J et al. HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. JOURNAL OF CLINICAL ONCOLOGY . 2021;39(13):1468-1478. doi: 10.1200/JCO.20.02761